Massimo TRIGGIANI | Publications

	2008
	Articolo in rivista
	A randomised, placebo-controlled, double blind phase III study of the efficacy and safety of recombinant human C1 inhibitor for the treatment of acute attacks in patients with hereditary angioedema MOLECULAR IMMUNOLOGY. Vol. 45. Pag.4118-4119 ISSN:0161-5890.
	Marco, Cicardi; Roberto, Perricone; Mauro, Cancian; Vincenzo, Montinaro; Enrico, Cillari; Teresa Gonzalez, Quevedo; Sergio, Neri; Triggiani, Massimo; Hilary, Longhurst; Cornelis, Hack; Rene, Verdonk; Bruno, Giannetti; Jan, Nuijens
	Digital Object Identifier (DOI): 10.1016/j.molimm.2008.08.069 Codice identificativo ISI: WOS:000260245000076
	Show it in Product Database (IRIS)

Massimo TRIGGIANI Publications